Inhibitor

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Inhibitor Report for: SN-38

Name Class
SN-38TypeDrug
Derivative of Irinotecan
Not A/B H target
Pro-Drug
Other_Name (10)
Chemical_Nomenclature(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
FormulaC22H20N2O5
CAS_number86639-52-3
MW392.4
Paper (27)
Commentactive metabolite of Irinotecan a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer. Also product of hydrolysis of NPC product of hydrolysis of Irinotecan by 9sphn-E93
Gene_locus9sphn-E93
human-CES2
CID104842
FamilyCarb_B_Bacteria
Carb_B_Chordata
InChIKeyFJHBVJOVLFPMQE-QFIPXVFZSA-N
CanonicalSMILESCCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)O
InChIInChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1

Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer